Evidence map›Paper›PMID 35635679›Full record

ArticleGeroScience2023

Modulation of nigral dopamine signaling mitigates parkinsonian signs of aging: evidence from intervention with calorie restriction or inhibition of dopamine uptake.

Michael F Salvatore, Ella A Kasanga, D Parker Kelley, Katy E Venable, Tamara R McInnis, Mark A Cantu, Jennifer Terrebonne, Kathryn Lanza, Samantha M Meadows, Ashley Centner and 2 more

Open access · greenAbstract read
In one paragraph

Article in GeroScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Michael F SalvatoreDepartment of Pharmacology & Neuroscience, University of North Texas Health Science Center, Fort Worth, TX, 76107, USA. Michael.salvatore@unthsc.edu.
Ella A KasangaDepartment of Pharmacology & Neuroscience, University of North Texas Health Science Center, Fort Worth, TX, 76107, USA.
D Parker KelleyPennington Biomedical Research Center, Baton Rouge, LA, USA.
Katy E VenablePennington Biomedical Research Center, Baton Rouge, LA, USA.
Tamara R McInnisDepartment of Pharmacology & Neuroscience, University of North Texas Health Science Center, Fort Worth, TX, 76107, USA.
Mark A CantuDepartment of Pharmacology & Neuroscience, University of North Texas Health Science Center, Fort Worth, TX, 76107, USA.
Jennifer TerrebonnePennington Biomedical Research Center, Baton Rouge, LA, USA.
Kathryn LanzaDepartment of Psychology, Binghamton University, Binghamton, NY, USA.
Samantha M MeadowsDepartment of Psychology, Binghamton University, Binghamton, NY, USA.
Ashley CentnerDepartment of Psychology, Binghamton University, Binghamton, NY, USA.
Christopher BishopDepartment of Psychology, Binghamton University, Binghamton, NY, USA.
Donald K IngramPennington Biomedical Research Center, Baton Rouge, LA, USA.
Binghamton University · USPennington Biomedical Research Center · USUniversity of North Texas · USUniversity of North Texas Health Science Center · US

Funding

Training in the Neurobiology of Aging and Alzheimer's DiseaseT32AG020494 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI ROBERT Clinton BARBER, NATHALIE SUMIEN · 2002 to 2026
$6.9M
NIA NIH HHS T32 AG020494
6 · The paper itself

Abstract

Identifying neurobiological mechanisms of aging-related parkinsonism, and lifestyle interventions that mitigate them, remain critical knowledge gaps. No aging study, from rodent to human, has reported loss of any dopamine (DA) signaling marker near the magnitude associated with onset of parkinsonian signs in Parkinson's disease (PD). However, in substantia nigra (SN), similar loss of DA signaling markers in PD or aging coincide with parkinsonian signs. Alleviation of these parkinsonian signs may be possible by interventions such as calorie restriction (CR), which augment DA signaling markers like tyrosine hydroxylase (TH) expression in the SN, but not striatum. Here, we interrogated respective contributions of nigral and striatal DA mechanisms to aging-related parkinsonian signs in aging (18 months old) rats in two studies: by the imposition of CR for 6 months, and inhibition of DA uptake within the SN or striatum by cannula-directed infusion of nomifensine. Parkinsonian signs were mitigated within 12 weeks after CR and maintained until 24 months old, commensurate with increased D

Indexed as

DopamineParkinson DiseaseAnimalsCaloric RestrictionGlial Cell Line-Derived Neurotrophic FactorHumansNomifensineRatsRats, Inbred F344Substantia NigraDopamineGlial Cell Line-Derived Neurotrophic FactorNomifensineAgingBradykinesiaCaloric restrictionDopamine receptorNigrostriatalParkinsonismTyrosine hydroxylase

Identifiers

PMID35635679
PMCPMC9886753
OpenAlexW4281708864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.